Disclosure Of First-Time Adoption [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183198

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
336,634,000 EUR
2,545,000 EUR
340,769,000 EUR
33,840,000 EUR
32,250,000 EUR
219,759,000 EUR
332,535,000 EUR
31,271,000 EUR
13,690,000 EUR
157,737,000 EUR
3,423,000 EUR
258,898,000 EUR
163,298,000 EUR
127,673,000 EUR
28,649,000 EUR
Comprehensive income
17,300,000 EUR
- EUR
- EUR
134,175,000 EUR
116,875,000 EUR
89,086,000 EUR
92,086,000 EUR
3,000,000 EUR
- EUR
- EUR
Profit (loss)
116,875,000 EUR
116,875,000 EUR
92,086,000 EUR
92,086,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.